Half-year Results

Tooru plc is pleased to announce its unaudited interim results for the six months to 30 June 2026.

Highlights

• EBITDA of over £1 million generated from our operating businesses during the first six months of 2026
• Continued growth of the OAF brand with increased distribution in major retailers

o increased listings with Tesco during the period

o new listings in Asda from April 2026

• New funds raised amounting to gross cash proceeds of £980,000 and debt conversion of £300,000
• Return of Pulsin to normal production and distribution

o improving margins due to reduction in costs through move to contract manufacturing

o new Swiss distribution agreement

• This is the first reporting period that includes all of the operating businesses for the full period.
• Post period end Market Rocket was sold enabling improved focus on managing and developing leading consumer brands.

Financial summary

The figures set out below are for the respective accounting periods which, other than the six months to 30 June 2026, do not include a full contribution from the Group's operating businesses.

Notes:

• For the six months ended 30 June 2025, the figures include a one-month contribution from the trading subsidiaries acquired at the end of May 2025.
• EBITDA for 2025 was calculated before deducting the costs incurred in connection with the RTO process in May 2025.

Chairman's Statement

I am pleased to present my Chairman's Statement for the six months to 30 June 2026.

This period represents the first reported accounting period which includes a full contribution from the businesses acquired from S-Ventures plc last year. Further details of the performance of our underlying businesses are set out in the CEO's Report.

However, in essence, Juvela and OAF have continued to perform strongly, particularly with OAF increasing its listings in Tesco and Asda. Despite a difficult start to the year, Pulsin has turned a corner, re-building its sales and reducing operating costs.

We have also raised some additional capital and, in line with our stated strategy, we have been actively looking at acquisitions, although we will only proceed if they meet our exacting criteria. Post-period end, we disposed of Market Rocket which will help us to focus on the building of exciting brands in the wellness sector.

We are optimistic that this progress will continue into the second half of 2026.

Nicholas Lee

Non-Executive Chairman

CEO's Report

We are pleased with the progress made across the Group during the first six months of the year, with our operating businesses delivering over £1 million of EBITDA in the period.

A segmental summary of the trading performance of our operating business is shown below which are directly comparable across the periods and represent 100% of the results for these businesses.

• After a slow 1st quarter, due to supply chain issues, Pulsin is now performing well and this should be reflected in the full year results. The improved EBITDA is due to the significant cost savings achieved following the change to outsourced production.
• Juvela has achieved strong growth in its retail OAF sales and sales in the prescription segment were broadly maintained, albeit slightly below the comparative period.
• Market Rocket continued to perform in line with the previous year.

OAF has made a particularly strong start to the year, delivering over 100% year-on-year growth in the first six months. This performance demonstrates the growing momentum within the business and provides us with confidence in its prospects for the remainder of the year and beyond. Distribution of the brand within our major retailer customers has grown markedly with increased listings in Tesco during the period and new listings in Asda from April 2026. Our prescription business continues to perform steadily and remains a stable contributor to the Group.

At Pulsin, we are encouraged to see the business returning to growth, reflecting the work undertaken to strengthen its proposition and position it for sustainable future development.

Overall, we are happy with the results achieved in the first half. The combination of strong growth at OAF, stability within the Juvela prescription business and renewed momentum at Pulsin demonstrates the progress being made across our portfolio.

We remain focused on executing our strategy, building on the momentum established to date and delivering further growth during the remainder of the year. This also included looking in detail at a significant acquisition, albeit after further work we decided not to proceed with it.

New funds were also raised, amounting to a gross cash figure of £980,000 and debt conversion of £300,000.

Post period end, Market Rocket was sold enabling improved focus on managing and developing leading consumer brands.

We look forward to the second half with confidence.

Scott Livingston

Chief Executive Officer

Unaudited consolidated Statement of Comprehensive Income

For the six months ended 30 June 2026

Notes to the condensed unaudited consolidated financial statements

For the six months ended 30 June 2026

General information

The consolidated financial statements for the six months ended 30 June 2026 are unaudited and were authorised for issue in accordance with a resolution of the Board of Directors.

Basis of preparation

The financial information set out in this interim report does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. The group's statutory financial statements for the period ended 31 December 2025, prepared under International Financial Reporting Standards (IFRS), have been filed with the Registrar of Companies. The auditor's report on those financial statements was unqualified and did not contain a statement under section 498 (2) or (3) of the Companies Act 2006.

The interim financial information has been prepared in accordance with the recognition and measurement principles of International Financial Reporting Standards (IFRS) and on the same basis and using the same accounting policies as used in the financial statements for the year ended 31 December 2025. The interim financial statements have not been audited or reviewed in accordance with the International Standard on Review Engagement 2410 issued by the Auditing Practices Board.

The financial statements have been prepared on a going concern basis under the historical cost convention.

The Directors believe that the going concern basis is appropriate for the preparation of the financial statements as the Company is in a position to meet all its liabilities as they fall due.

These condensed consolidated interim financial statements comprise the accounts of the parent company and those of the five subsidiaries for the six months to 30 June 2026, after elimination of all material intercompany balances and transactions.

Loss per share

The total basic loss per share of 0.0196p is based on the loss attributable to equity owners of the company divided by the number of shares in issue during the period.

Approval of Interim Finance Statements

These interim financial statements were approved by the Board of Directors on 2 September 2026.